Eli Lilly (NYSE: LLY) EVP receives 1,196-share stock award

Rhea-AI Filing Summary

Eli Lilly and Company executive Adrienne S. Brown reported an acquisition of company stock. On February 9, 2026, the EVP, President LLY Imm received a grant or award of 1,196.308 shares of Eli Lilly common stock at $1,044.67 per share. Following this award, Brown directly beneficially owned 4,921.308 shares of Eli Lilly common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brown Adrienne S

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS IN 46285

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, President LLY Imm

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		A		1,196.308	A	$1,044.67	4,921.308	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Jonathan Groff for Adrienne Brown, pursuant to authorization on file	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Eli Lilly (LLY) report for Adrienne Brown?

Eli Lilly reported that executive Adrienne S. Brown acquired 1,196.308 shares of common stock as a grant or award on February 9, 2026, at $1,044.67 per share, increasing her direct holdings to 4,921.308 shares.

What role does Adrienne S. Brown hold at Eli Lilly (LLY) in this Form 4?

Adrienne S. Brown is identified as an officer of Eli Lilly, serving as EVP, President LLY Imm. The Form 4 reflects her status as a company executive receiving a stock grant reported under insider ownership rules.

How many Eli Lilly (LLY) shares does Adrienne Brown own after this transaction?

After the reported grant, Adrienne S. Brown beneficially owns 4,921.308 Eli Lilly common shares directly. This figure includes the newly awarded 1,196.308 shares disclosed in the February 9, 2026 Form 4 filing.

Was Adrienne Browns Eli Lilly (LLY) transaction a purchase or an award?

The transaction is classified as a grant, award, or other acquisition rather than an open-market purchase. It is coded as an acquisition ("A") and described as a grant or award of 1,196.308 Eli Lilly common shares.

At what price was Adrienne Browns Eli Lilly (LLY) stock award valued?

The awarded 1,196.308 Eli Lilly common shares were reported at a price of $1,044.67 per share. This price is used in the Form 4 to indicate the value associated with the grant or award on February 9, 2026.

Is Adrienne S. Browns Eli Lilly (LLY) ownership direct or indirect after this transaction?

The Form 4 identifies Adrienne S. Browns 4,921.308 Eli Lilly common shares as directly owned. The ownership code is "D" for direct, and no indirect ownership nature is specified in the provided data.